NYSE:KAPA | Cash Flow Statement | Kairos Pharma, LTD.

Complete source-backed cash-flow history.

Available history
2023-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.39M
2026-03-31-$1.65M-$1.04M$220,000.00
2025-12-31-$1.37M-$1.08M$0.00
2025-09-30-$1.4M
2025-06-30-$1.42M
2025-03-31-$1.26M-$714,000.00$3.06M
2024-12-31-$980,000.00-$1.8M-$142,000.00
2024-09-30-$1.05M
2024-06-30-$253,000.00
2024-03-31-$323,000.00$36,000.00-$89,000.00
2023-12-31-$1.12M$66,000.00-$72,000.00
2023-09-30-$312,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$5.45M-$3.44M$6.66M
2024-12-31-$2.6M-$3.96M$5.13M
2023-12-31-$1.81M$81,000.00-$425,000.00